Jefferies Sticks to Their Buy Rating for Sanofi (SNYNF)
Jefferies analyst Benjamin Jackson CFA maintained a Buy rating on Sanofi today and set a price target of €100.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Jackson CFA is ranked #4279 out of 11984 analysts.
In addition to Jefferies, Sanofi also received a Buy from Deutsche Bank ‘s Emmanuel Papadakis in a report issued on January 27. However, on the same day, Citi initiated coverage with a Hold rating on Sanofi (Other OTC: SNYNF).
SNYNF market cap is currently €96.6B and has a P/E ratio of 10.79.
Read More on SNYNF:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.